The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling

J Mol Cell Cardiol. 2019 Mar:128:160-178. doi: 10.1016/j.yjmcc.2019.01.027. Epub 2019 Jan 31.

Abstract

High mobility group protein AT-hook 2 (HMGA2), an architectural transcription factor, has previously been reported to play an essential role in regulating the expression of many genes through architectural remodeling processes. However, the effects of HMGA2 on cardiovascular disease, especial cardiac remodeling, is unclear. This study was aimed at investigating the functional role of HMGA2 in pressure overload-induced cardiac remodeling. Mice that were subjected to aortic banding (AB) for 8 weeks developed myocardial hypertrophy and cardiac dysfunction, which were associated with altered expression of HMGA2. Cardiac-specific expression of the human HMGA2 gene in mice with an adeno-related virus 9 delivery system ameliorated cardiac remodeling and improve cardiac function in response to pressure overload by activating PPARγ/NRF2 signaling. Knockdown of HMGA2 by AAV9-shHMGA2 accelerated cardiac remodeling after 1 weeks of AB surgery. Additionally, knockdown of heart PPARγ largely abolished HMGA2 overexpression-mediated cardioprotection. HMGA2-mediated cardiomyocyte protection was largely abrogated by knocking down NRF2 and inhibiting PPARγ in cardiomyocytes. PPARγ activation was mediated by C/EBPβ, which directly interacted with HMGA2. Knocking down C/EBPβ offset the effects of HMGA2 on PPARγ activation and cardioprotection. These findings show that the overexpression of HMGA2 ameliorates the remodeling response to pressure overload, and they also imply that the upregulation of HMGA2 may become a treatment strategy in cardiac pathologies.

Keywords: C/EBPβ; Cardiac remodeling; HMGA2; NRF2; PPARγ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aorta / metabolism
  • Aorta / pathology
  • Atrial Remodeling / genetics
  • CCAAT-Enhancer-Binding Protein-beta / genetics*
  • Cardiomegaly / genetics
  • Cardiomegaly / pathology
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / pathology
  • Gene Expression Regulation / genetics
  • Gene Knockdown Techniques
  • HMGA2 Protein / genetics*
  • Humans
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • NF-E2-Related Factor 2 / genetics
  • PPAR gamma / genetics*
  • Pressure / adverse effects

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • Cebpb protein, mouse
  • HMGA2 Protein
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • PPAR gamma
  • Pparg protein, mouse